Literature DB >> 3056401

Effect of diabetes on guanine nucleotide exchange factor activity in skeletal muscle and heart.

S R Kimball1, L S Jefferson.   

Abstract

The present study examined the effects of diabetes and insulin treatment of diabetic rats on the activity of the protein synthesis initiation factor, the guanine nucleotide exchange factor. In extracts from gastrocnemius and psoas muscles from two-day diabetic rats, guanine nucleotide exchange factor activity was reduced to 80% and 67% of control values, respectively. Insulin treatment (2 h) restored guanine nucleotide exchange factor activity to control values in both muscles. In contrast, guanine nucleotide exchange factor activity was unchanged in extracts from either soleus muscle or heart from diabetic rats compared to controls. Also, insulin treatment did not increase guanine nucleotide exchange factor activity in extracts from soleus and heart. The results suggest that the diabetes-induced impairment in peptide-chain initiation in fast-twitch skeletal muscle (i.e. gastrocnemius and psoas) is related to an inhibition of guanine nucleotide exchange factor activity and that slow-twitch muscle is spared from the effect on initiation due to the preservation of guanine nucleotide exchange factor activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056401     DOI: 10.1016/s0006-291x(88)80900-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.

Authors:  Xuemin Wang; Maarten Janmaat; Anne Beugnet; Fiona E M Paulin; Christopher G Proud
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 2.  Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise.

Authors:  Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

Review 3.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

4.  Regulation of protein synthesis in Swiss 3T3 fibroblasts. Rapid activation of the guanine-nucleotide-exchange factor by insulin and growth factors.

Authors:  G I Welsh; C G Proud
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

5.  Ectopic expression of eIF2Bepsilon in rat skeletal muscle rescues the sepsis-induced reduction in guanine nucleotide exchange activity and protein synthesis.

Authors:  Alexander P Tuckow; Thomas C Vary; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-18       Impact factor: 4.310

Review 6.  Molecular mechanisms for the control of translation by insulin.

Authors:  C G Proud; R M Denton
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

7.  Nutrients differentially regulate multiple translation factors and their control by insulin.

Authors:  L E Campbell; X Wang; C G Proud
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo.

Authors:  X Wang; F E Paulin; L E Campbell; E Gomez; K O'Brien; N Morrice; C G Proud
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

9.  Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle.

Authors:  Douglas R Bolster; Neil Kubica; Stephen J Crozier; David L Williamson; Peter A Farrell; Scot R Kimball; Leonard S Jefferson
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

Review 10.  Regulation of initiation of protein synthesis by insulin in skeletal muscle.

Authors:  S R Kimball; L S Jefferson
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.